56 related articles for article (PubMed ID: 22041172)
1. Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents.
Bargagna B; Ciccone L; Nencetti S; Santos MA; Chaves S; Camodeca C; Orlandini E
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641559
[TBL] [Abstract][Full Text] [Related]
2. Berberine: a potential multipotent natural product to combat Alzheimer's disease.
Ji HF; Shen L
Molecules; 2011 Aug; 16(8):6732-40. PubMed ID: 21829148
[TBL] [Abstract][Full Text] [Related]
3. Phytochemical Quantification and the In Vitro Acetylcholinesterase Inhibitory Activity of Phellodendron chinense and Its Components.
Kim YJ; Lim HS; Kim Y; Lee J; Kim BY; Jeong SJ
Molecules; 2017 Jun; 22(6):. PubMed ID: 28574473
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
5. Berberine: A Promising Treatment for Neurodegenerative Diseases.
Cheng Z; Kang C; Che S; Su J; Sun Q; Ge T; Guo Y; Lv J; Sun Z; Yang W; Li B; Li X; Cui R
Front Pharmacol; 2022; 13():845591. PubMed ID: 35668943
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.
Qi YY; Heng X; Yao ZY; Qu SY; Ge PY; Zhao X; Ni SJ; Guo R; Yang NY; Zhang QC; Zhu HX
Drug Des Devel Ther; 2022; 16():931-950. PubMed ID: 35391788
[TBL] [Abstract][Full Text] [Related]
7. Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer's Disease.
Jana A; Bhattacharjee A; Das SS; Srivastava A; Choudhury A; Bhattacharjee R; De S; Perveen A; Iqbal D; Gupta PK; Jha SK; Ojha S; Singh SK; Ruokolainen J; Jha NK; Kesari KK; Ashraf GM
Mol Neurobiol; 2022 Jun; 59(6):3512-3528. PubMed ID: 35347587
[TBL] [Abstract][Full Text] [Related]
8. Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice.
de Oliveira RL; Voss GT; da C Rodrigues K; Pinz MP; Biondi JV; Becker NP; Blodorn E; Domingues WB; Larroza A; Campos VF; Alves D; Wilhelm EA; Luchese C
Psychopharmacology (Berl); 2022 Jan; 239(1):59-81. PubMed ID: 35013761
[TBL] [Abstract][Full Text] [Related]
9. Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release.
Ghaffarzadegan R; Khoee S; Rezazadeh S
Daru; 2020 Jun; 28(1):237-252. PubMed ID: 32307652
[TBL] [Abstract][Full Text] [Related]
10. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
Fan D; Liu L; Wu Z; Cao M
Curr Neuropharmacol; 2019; 17(6):563-579. PubMed ID: 29676231
[TBL] [Abstract][Full Text] [Related]
11. The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer's disease model.
He Q; Huang G; Chen Y; Wang X; Huang Z; Chen Z
Neurochem Res; 2017 Nov; 42(11):3061-3072. PubMed ID: 28669120
[TBL] [Abstract][Full Text] [Related]
12.
Mohammadzadeh N; Mehri S; Hosseinzadeh H
Iran J Basic Med Sci; 2017 May; 20(5):538-551. PubMed ID: 28656089
[No Abstract] [Full Text] [Related]
13. ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.
Marco-Contelles J; Unzeta M; Bolea I; Esteban G; Ramsay RR; Romero A; Martínez-Murillo R; Carreiras MC; Ismaili L
Front Neurosci; 2016; 10():294. PubMed ID: 27445665
[TBL] [Abstract][Full Text] [Related]
14. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
Front Neurosci; 2016; 10():205. PubMed ID: 27252617
[TBL] [Abstract][Full Text] [Related]
15. Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.
Dias KS; Viegas C
Curr Neuropharmacol; 2014 May; 12(3):239-55. PubMed ID: 24851088
[TBL] [Abstract][Full Text] [Related]
16. Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.
Agis-Torres A; Sölhuber M; Fernandez M; Sanchez-Montero JM
Curr Neuropharmacol; 2014 Jan; 12(1):2-36. PubMed ID: 24533013
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents.
Zhang L; Li J; Ma F; Yao S; Li N; Wang J; Wang Y; Wang X; Yao Q
Molecules; 2012 Sep; 17(10):11294-302. PubMed ID: 23011273
[TBL] [Abstract][Full Text] [Related]
18. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
Jiang H; Wang X; Huang L; Luo Z; Su T; Ding K; Li X
Bioorg Med Chem; 2011 Dec; 19(23):7228-35. PubMed ID: 22041172
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
